Renovia Inc., a medical technology company that was co-founded by Marc Beer, will continue with its development of new line products after securing round two funding. The 42 million dollar funding that was obtained by Marc Beer will help the firm in developing several new products for pelvic floor disorders. The 42 million dollar funding comprised of a 32 million dollar series B funding and an additional 10 million dollars venture debt.
At the helm of Renovia is Marc Beer who serves as the firms CEO. Marc Beer has decades of experience in the development and commercialization of enterprises in the world of biotechnology and pharmaceuticals. Renovia Inc. is a Medtech company that focuses on the development of a wide range of diagnostic and therapeutic products that help in the treatment of pelvic floor disorders
Renovia Inc. under Marc Beer leadership has achieved a lot in the MedTech industry. The firm among its many accomplishments includes its first product the Leva that got approval from FDA in April of 2018. Renovia longtime investment partners the Longwood Fund was one of the healthcare investment firms that joined in the Series B funding. Other participants in the round two funding include Perceptive Advisers and the Missouri based Ascension Ventures. The funds were injected into the firm with the objective of ensuring that Renovia continues with the development and testing of four new products. Besides the four products, Beer intends to establish a new generation of the Leva product. Learn more: https://renoviainc.com/leadership/
Beer while giving insights on the funding acknowledged the support accorded to Renovia by the consortium of leading health care investors. Beer thanked the firms for coming on board to share in the firm’s vision of bettering the diagnosis and treatment of the disorder. Beer as the vision carrier hopes to lead Renovia’s development agenda that will encompass the use of innovative and proprietary sensor technologies. According to Beer the coming together of the firms along with the merging of their technologies will provide clients with valuable information including the introduction of new treatment plans. Beer added that with increased innovations and understanding of the disorder the cost of healthcare would eventually come down. Renovia Inc. is committed and dedicated to ensuring that pelvic health is restored through the provision of patient-centered solutions that will help strengthen the pelvic floor muscles.
Marc Beer is a serial entrepreneur who has successfully led the establishment of various startups in the healthcare industry. Beer co-founded Renovia Inc. in 2016 alongside Ramon Iglesias and Yolanda Lorie. Beer and expertise and track record earned Renovia trust and confidence that attracted investors who participated in the Series B funding. Other firms that Beer successfully established include the NASDAQ listed ViaCell that he founded in the year 2000.